Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 9Gynecologic 5Gastrointestinal 4Thoracic 3Head & Neck 3Tumor-Agnostic 2Genitourinary 2Plasma cell 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Urinary Incontinence, Stress 1Urinary Incontinence 1Urinary Bladder Neoplasms 1Prostatic Neoplasms 1

Interventions

Docetaxel 409pembrolizumab 331Prednisone 289enzalutamide 283Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 252Abiraterone Acetate 217Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 117Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 106cabozantinib 104atezolizumab 104Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Population Groups × Genitourinary × Clear all
NCT04804839 2024-03-26

Comparison of the Effectiveness of Different Conservative Treatment Protocols in Postprostatectomy Urinary Incontinence

Hacettepe University

Phase NA Completed
72 enrolled
Genitourinary

Prostatic Neoplasms, Urinary Incontinence, Urinary Incontinence, Stress

NCT02676180 2023-12-08

DETECT I

University College, London

Completed
3,700 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡